YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine
- Written by PR Newswire
![]() |
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the U.S. Food and Drug...
Read more: YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine















